Drug intelligence / Profile preview

Phong Dan

Development stage: Unknown
Lead developer: Mediplantex
Modality: Small Molecules
Administration: Oral

Overview

Phong Dan is a traditional herbal formulation developed and manufactured by Mediplantex National Pharmaceutical Joint Stock Company in Vietnam. Indicated for the treatment of rheumatism, joint disorders, back pain, sciatica, and spinal pain, the product is formulated from 13 medicinal herbs, including *Dipsacus*, *Saposhnikovia*, *Achyranthes*, *Paeonia*, *Eucommia*, *Angelica*, *Angelica sinensis*, *Astragalus*, *Strychnos*, *Dioscorea*, and *Ligusticum*. The medicine operates according to traditional medicine principles to reduce inflammation, alleviate pain, improve blood circulation, and strengthen liver and kidney functions. It is registered in Vietnam under the number VD-26637-17 and is available in a hard capsule dosage form.

Brand names: Phong DanThuốc khớp Phong Dan
Other names: Phong Dan joint medicine

Beyond the preview

Go deeper on Phong Dan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phong Dan.

Explore the full profile